Literature DB >> 7767636

Scope and limitations of gene therapy.

D J Weatherall1.   

Abstract

Although there are still many technical difficulties to be overcome, recent advances in the molecular and cellular biology of gene transfer have made it likely that gene therapy will soon start to play an increasing role in clinical practice. It will not be restricted to the management of monogenic disorders, but will have applications across many other fields of medicine, particularly the treatment of cancer and infectious disease.

Entities:  

Mesh:

Year:  1995        PMID: 7767636     DOI: 10.1093/oxfordjournals.bmb.a072939

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  5 in total

Review 1.  Gene therapy for cancer--in the dock, blown off course or full speed ahead?

Authors:  R C Vile
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

2.  Sense, antisense, nonsense: where's the right way?

Authors:  G Bricca
Journal:  J Mol Med (Berl)       Date:  1995-08       Impact factor: 4.599

Review 3.  Prospects for genetic intervention in primary open-angle glaucoma.

Authors:  M K Wirtz; T S Acott; J R Samples; J C Morrison
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

4.  Cationic facial amphiphiles: a promising class of transfection agents.

Authors:  S Walker; M J Sofia; R Kakarla; N A Kogan; L Wierichs; C B Longley; K Bruker; H R Axelrod; S Midha; S Babu; D Kahne
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

5.  LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives.

Authors:  Faisal A Al-Allaf; Charles Coutelle; Simon N Waddington; Anna L David; Richard Harbottle; Michael Themis
Journal:  Int Arch Med       Date:  2010-12-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.